A
Alexandra Gomez-Arteaga
H指数:9
被引数:292
浏览量:0
个人简介
暂无内容
教育背景
暂无内容
工作经历
暂无内容
荣誉奖项
暂无内容
Epigenetic Priming with Azacitidine Prior to Allogeneic Hematopoietic Stem Cell Transplantation for Myeloid Malignancies
在骨髓恶性肿瘤患者异基因造血干细胞移植前采用阿扎胞苷进行表观遗传预激
SOHO State of the Art Updates and Next Questions | Best of Stem Cell Transplant: Recent Advances in Allogeneic Hematopoietic Cell Transplantation
SOHO 技术现状更新与后续问题 | 造血干细胞移植最佳实践:同种异基因造血细胞移植的最新进展
Racial and ethnic disparities in brain-to-vein time among patients receiving CD19 CAR-T cell therapy for relapsed/refractory DLBCL
接受CD19 CAR-T细胞治疗的复发/难治性DLBCL患者中脑静脉时间的人种和民族差异
Real-world assessment of prophylactic anakinra on neurotoxicity and cytokine release syndrome after CD19 CAR T-cell therapy in R/R B-cell lymphoma: An inverse probability of treatment weighting analysis
R/R B细胞淋巴瘤患者接受CD19 CAR T细胞疗法后,预防性使用阿那白滞素对神经毒性和细胞因子释放综合征影响的真实世界评估:一项逆概率治疗加权分析
Orca-T versus allogeneic hematopoietic stem cell transplantation (PRECISION-T): a multicenter, randomized phase 3 trial
Orca-T与异基因造血干细胞移植(PRECISION-T):一项多中心、随机III期试验
Blood
IF23.1
Understanding Diversity: An ASTCT-NMDP ACCESS Initiative Survey of the Hematopoietic Cell Transplant and Cellular Therapy Workforce in the United States
理解多样性:ASTCT-NMDP ACCESS计划对美国造血细胞移植与细胞治疗从业人员的一项调查
Availability of suitable domestic cord blood grafts for adult allograft recipients with hematologic malignancies
适合成人血液系统恶性肿瘤异基因移植受者的合适自体脐带血移植物的可用性
Transplant Outcomes in Myelofibrosis: Impact of Donor Type (Cord Blood Grafts Supported by CD34+selected Cells [Haplo-Cord] Versus Matched Donors)
骨髓纤维化的移植结果: 供体类型的影响 (由CD34选择的细胞 [haplo-cord] 支持的脐带血移植物与匹配的供体)
A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome
中重度急性呼吸窘迫综合征不变自然杀伤T细胞治疗的1/2期临床试验
NATURE COMMUNICATIONS
IF15.7

